# Adapalene Gel 0.3% Versus Tretinoin 0.05% Emollient Cream for Treatment of Photodamage

> **NCT00647556** · PHASE3 · COMPLETED · sponsor: **Galderma R&D** · enrollment: 30 (actual)

## Conditions studied

- Photoaging

## Interventions

- **DRUG:** adapalene gel, 0.3%
- **DRUG:** tretinoin 0.05% emollient cream

## Key facts

- **NCT ID:** NCT00647556
- **Lead sponsor:** Galderma R&D
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04
- **Primary completion:** 2010-01
- **Final completion:** 2010-01
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2022-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00647556

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00647556, "Adapalene Gel 0.3% Versus Tretinoin 0.05% Emollient Cream for Treatment of Photodamage". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT00647556. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*